Literature DB >> 18953352

Engineering microRNA responsiveness to decrease virus pathogenicity.

Elizabeth J Kelly1, Elizabeth M Hadac, Suzanne Greiner, Stephen J Russell.   

Abstract

The cellular tropisms of eukaryotic viruses are shaped by their need for entry receptors and intracellular transcription factors. Here we show that viral tropisms can also be regulated by tissue-specific microRNAs (miRNAs). Target sequences complementary to muscle-specific miRNAs were inserted into the 3' untranslated region (UTR) of an oncolytic picornavirus that causes lethal myositis in tumor-bearing mice. The recombinant virus still propagated in subcutaneous tumors, causing total regression and sustained viremia, but could not replicate in cells expressing complementary miRNAs and therefore did not cause myositis. This altered tropism was not due to insertional attenuation, as a control virus containing a 3' UTR insert with a disrupted miRNA target sequence fully retained its lethal myotropism. Tissue-specific destabilization of viral genomes by miRNA target insertion provides a potentially versatile new mechanism for controlling the tropism of replicating viruses for therapy and may serve as a new modality for attenuating viruses for vaccine purposes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18953352     DOI: 10.1038/nm.1776

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  117 in total

1.  In vivo delivery of cytoplasmic RNA virus-derived miRNAs.

Authors:  Ryan A Langlois; Jillian S Shapiro; Alissa M Pham; Benjamin R tenOever
Journal:  Mol Ther       Date:  2011-11-15       Impact factor: 11.454

2.  Hematopoietic-specific targeting of influenza A virus reveals replication requirements for induction of antiviral immune responses.

Authors:  Ryan A Langlois; Andrew Varble; Mark A Chua; Adolfo García-Sastre; Benjamin R tenOever
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-09       Impact factor: 11.205

3.  In vitro and in vivo characterization of microRNA-targeted alphavirus replicon and helper RNAs.

Authors:  Kurt I Kamrud; V McNeil Coffield; Gary Owens; Christin Goodman; Kim Alterson; Max Custer; Michael A Murphy; Whitney Lewis; Sarah Timberlake; Elizabeth K Wansley; Peter Berglund; Jonathan Smith
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

4.  Oncolytic Activity of Targeted Picornaviruses Formulated as Synthetic Infectious RNA.

Authors:  Noura B Elsedawy; Rebecca A Nace; Stephen J Russell; Autumn J Schulze
Journal:  Mol Ther Oncolytics       Date:  2020-05-19       Impact factor: 7.200

Review 5.  The role of RNAi and microRNAs in animal virus replication and antiviral immunity.

Authors:  Jennifer L Umbach; Bryan R Cullen
Journal:  Genes Dev       Date:  2009-05-15       Impact factor: 11.361

6.  A versatile RNA vector for delivery of coding and noncoding RNAs.

Authors:  Sonja Schmid; Lum C Zony; Benjamin R tenOever
Journal:  J Virol       Date:  2013-12-04       Impact factor: 5.103

7.  Drosha as an interferon-independent antiviral factor.

Authors:  Jillian S Shapiro; Sonja Schmid; Lauren C Aguado; Leah R Sabin; Ari Yasunaga; Jaehee V Shim; David Sachs; Sara Cherry; Benjamin R tenOever
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-28       Impact factor: 11.205

8.  Attenuation of vesicular stomatitis virus encephalitis through microRNA targeting.

Authors:  Elizabeth J Kelly; Rebecca Nace; Glen N Barber; Stephen J Russell
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

9.  Replication of many human viruses is refractory to inhibition by endogenous cellular microRNAs.

Authors:  Hal P Bogerd; Rebecca L Skalsky; Edward M Kennedy; Yuki Furuse; Adam W Whisnant; Omar Flores; Kimberly L W Schultz; Nicole Putnam; Nicholas J Barrows; Barbara Sherry; Frank Scholle; Mariano A Garcia-Blanco; Diane E Griffin; Bryan R Cullen
Journal:  J Virol       Date:  2014-05-07       Impact factor: 5.103

10.  Degradation of host microRNAs by poxvirus poly(A) polymerase reveals terminal RNA methylation as a protective antiviral mechanism.

Authors:  Simone Backes; Jillian S Shapiro; Leah R Sabin; Alissa M Pham; Ismarc Reyes; Bernard Moss; Sara Cherry; Benjamin R tenOever
Journal:  Cell Host Microbe       Date:  2012-08-16       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.